Test Price
2,800 AEDโ Home Collection Available
KIF1C Gene Spastic Ataxia Type 2, Autosomal Recessive Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed genetics professionals.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Clinical Test Overview
The KIF1C Gene Spastic Ataxia Type 2, Autosomal Recessive Genetic Test identifies pathogenic variants in the KIF1C gene associated with hereditary spastic ataxia, enabling definitive molecular diagnosis and informed family planning. This next-generation sequencing assay covers all coding exons and splice junctions with high read depth, ensuring detection of single nucleotide variants, indels, and copy number changes.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next Generation Sequencing) โ full gene coverage | Targeted mutation panel (limited variants) |
| Sensitivity & Precision | >99.9% for SNVs/indels, <1% VAF detection | May miss novel/private variants |
| Turnaround Time | 3 โ 4 Weeks | 4 โ 6 Weeks |
| Sample Options | Whole Blood (EDTA), Extracted DNA, or FTA Card | Blood only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA Registration ID: 9294403), Consultant Medical Genetics: โThis comprehensive sequencing test provides a molecular window into the genetic basis of spastic ataxia type 2. However, results must be contextualised within the complete clinical evaluation, family pedigree, and neurological examination. A negative finding does not exclude alternative hereditary ataxias or other neurodegenerative conditions. Any variant of uncertain significance or secondary finding warrants careful discussion with a qualified genetic counsellor before making personal or reproductive decisions. This data is intended to empower, not to alarm.โ
Safety Advisory & Patient Precautions
- This genetic test is not intended for emergency diagnosis of acute neurological deterioration. If you experience sudden severe weakness, respiratory difficulty, or loss of consciousness, proceed immediately to the nearest emergency department.
- Do not alter or discontinue any prescribed medication regimen without direct consultation with your treating physician.
- Informed consent and pre-test genetic counselling with a three-generation pedigree chart are mandatory prior to sample collection.
- Exclusion criteria include individuals unable to provide informed consent, active uncontrolled psychiatric illness, or recent blood transfusion (within 2 weeks) which may necessitate rescheduling.
Patient FAQ & Clinical Guidance
1. What exactly does the KIF1C gene test detect?
Direct Answer: The test detects pathogenic mutations in the KIF1C gene linked to autosomal recessive spastic ataxia type 2, confirming the diagnosis at the molecular level and enabling carrier testing and prenatal planning.
2. How is the sample collected and when will I receive my results?
Direct Answer: A certified phlebotomist collects a blood sample (EDTA tube), dried blood spot on FTA card, or extracted DNA during a convenient home visit. Results are reported within 3 to 4 weeks via secure electronic delivery.
3. Is this genetic test covered by my health insurance in the UAE?
Direct Answer: Coverage varies by plan and insurer. We verify your eligibility and offer direct billing whenever possible. Contact our team on WhatsApp at +971 54 548 8731 for instant confirmation and pre-authorisation assistance.
4. What does a variant of uncertain significance (VUS) mean for my results?
Direct Answer: A VUS indicates a genetic change whose clinical impact is not yet fully understood. Our team provides complimentary follow-up counselling and, where appropriate, family segregation studies to reclassify the variant over time.
UAE Regulatory & Data Privacy Adherence
This service strictly adheres to UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed with full confidentiality, and patients retain the right to access, correct, and request deletion of their personal information.
Clinical testing safety and patient consent procedures comply with Federal Decree-Law No. 4 of 2016 on Medical Liability.
DHA Facility License: 1143 | ISO 9001:2015 Certified โ Certificate: INT/EGQ/2509DA/3139
Corporate Laboratory: DNA Labs UAE
Clinical & Logistical Metadata
| Test Name | KIF1C Gene Spastic Ataxia Type 2, Autosomal Recessive Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 โ 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) โ full gene coverage including all coding exons and splice junctions |
| ICD-10-CM Code | G11.4 |
| LOINC Code | 81247-9 |
| DHA Facility License & Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians